Blue Ridge Cancer Care Announces Establishment of The Research Institute at Blue Ridge Cancer Ca
6/15/2021
Blue Ridge Cancer Care Announces the Establishment of The Research Institute at Blue Ridge Cancer Care
The Research Institute will continue to advance clinical research in Southwest VA.
Roanoke, VA (6/15/2021) — Blue Ridge Cancer Care (BRCC), a premier cancer care center with more than 40 years of experience providing service to patients battling cancer and blood diseases, has established The Research Institute at Blue Ridge Cancer Care. The Research Institute is the next step in the advancement of the longstanding clinical research program at BRCC. Through their collaboration with The US Oncology Network and independent sponsors, The Research Institute at Blue Ridge Cancer Care is the largest and most active oncology clinical research program in Southwest Virginia, providing cancer patients access to the latest therapies and treatment options in their community.
By conducting all phases of oncology clinical research trials, The Research Institute at Blue Ridge Cancer Care offers more options for cancer patients to participate in clinical trials locally. Providing patients access to cutting edge clinical trials in Southwest Virginia is a longstanding goal of the research program at Blue Ridge Cancer Care and now more than ever this goal is being realized. Cancer patients throughout Southwest Virginia and nationwide will benefit from the availability of additional FDA-approved therapies, leading to the potential for better outcomes.
Blue Ridge Cancer Care conducts clinical trials through US Oncology Research, one of the largest community-based cancer research programs in the country that has played a role in more than 100 FDA-approved cancer therapies.
“We’re proud to establish The Research Institute and offer our patients another level of groundbreaking treatment options through clinical trials,” said BRCC Practice President David Buck, M.D. “This expanded access allows us to provide patients with the most advanced cancer treatments available.”
“The Research Institute at Blue Ridge Cancer Care is yet another facet of the comprehensive cancer care we strive to provide our patients. We want to provide even more options for our patients by delivering tomorrow’s treatments today” said Site Research Leader Jerry Goldschmidt, M.D.
To learn more about clinical research at Blue Ridge Cancer Care or to find available trials, please visit BlueRidgeCancerCare.com.
About Blue Ridge Cancer Care
For more than 40 years, Blue Ridge Cancer Care (BRCC) has helped patients with cancer and blood disorders get the most out of life. As a privately-owned practice of 19 physicians, BRCC serves patients in nine locations throughout Southwest Virginia. The high-quality care provided at BRCC includes state-of-the-art technologies and treatments delivered in a compassionate and comfortable setting. BRCC’s model of integrated community-based care maximizes patient and family convenience, while offering patients comprehensive care close to home.
Blue Ridge Cancer Care is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,380 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. BRCC also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.